Literature DB >> 22073494

Angioedema: an overview and update.

Christina E Ciaccio1.   

Abstract

Angioedema is an increasing cause of hospitalizations in the United States. This syndrome presents with non-pitting, asymmetric swelling of the face, lips, tongue, larynx, genitalia, and extremities, although any part of the body can be involved. Common causes of angioedema include allergic reactions and ACE inhibitors. Hereditary angioedema is a rare form of angioedema that can be diagnosed by screening with a C4 level. In 2009, three new treatments for hereditary angioedema were approved for use in the United States, revolutionizing management of this rare disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22073494      PMCID: PMC6188378     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  19 in total

1.  Erythema marginatum preceding an acute oedematous attack of hereditary angioneurotic oedema.

Authors:  H Farkas; G Harmat; A Fáy; B Fekete; I Karádi; B Visy; L Varga
Journal:  Acta Derm Venereol       Date:  2001 Oct-Nov       Impact factor: 4.437

2.  Bradykinin-mediated angioedema.

Authors:  Juerg Nussberger; Massimo Cugno; Marco Cicardi
Journal:  N Engl J Med       Date:  2002-08-22       Impact factor: 91.245

3.  Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant.

Authors:  Peter W Schmidt; Michael M Hirschl; Franz Trautinger
Journal:  J Am Acad Dermatol       Date:  2010-06-15       Impact factor: 11.527

4.  Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study.

Authors:  M M Frank; J S Sergent; M A Kane; D W Alling
Journal:  N Engl J Med       Date:  1972-04-13       Impact factor: 91.245

5.  Ecallantide for the treatment of acute attacks in hereditary angioedema.

Authors:  Marco Cicardi; Robyn J Levy; Donald L McNeil; H Henry Li; Albert L Sheffer; Marilyn Campion; Patrick T Horn; William E Pullman
Journal:  N Engl J Med       Date:  2010-08-05       Impact factor: 91.245

6.  Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.

Authors:  Marco Cicardi; Aleena Banerji; Francisco Bracho; Alejandro Malbrán; Bernd Rosenkranz; Marc Riedl; Konrad Bork; William Lumry; Werner Aberer; Henning Bier; Murat Bas; Jens Greve; Thomas K Hoffmann; Henriette Farkas; Avner Reshef; Bruce Ritchie; William Yang; Jürgen Grabbe; Shmuel Kivity; Wolfhart Kreuz; Robyn J Levy; Thomas Luger; Krystyna Obtulowicz; Peter Schmid-Grendelmeier; Christian Bull; Brigita Sitkauskiene; William B Smith; Elias Toubi; Sonja Werner; Suresh Anné; Janne Björkander; Laurence Bouillet; Enrico Cillari; David Hurewitz; Kraig W Jacobson; Constance H Katelaris; Marcus Maurer; Hans Merk; Jonathan A Bernstein; Conleth Feighery; Bernard Floccard; Gerald Gleich; Jacques Hébert; Martin Kaatz; Paul Keith; Charles H Kirkpatrick; David Langton; Ludovic Martin; Christiane Pichler; David Resnick; Duane Wombolt; Diego S Fernández Romero; Andrea Zanichelli; Francesco Arcoleo; Jochen Knolle; Irina Kravec; Liying Dong; Jens Zimmermann; Kimberly Rosen; Wing-Tze Fan
Journal:  N Engl J Med       Date:  2010-08-05       Impact factor: 91.245

7.  Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.

Authors:  Bruce L Zuraw; Paula J Busse; Martha White; Joshua Jacobs; William Lumry; James Baker; Timothy Craig; J Andrew Grant; David Hurewitz; Leonard Bielory; William E Cartwright; Majed Koleilat; Walter Ryan; Oren Schaefer; Michael Manning; Pragnesh Patel; Jonathan A Bernstein; Roger A Friedman; Robert Wilkinson; David Tanner; Gary Kohler; Glenne Gunther; Robyn Levy; James McClellan; Joseph Redhead; David Guss; Eugene Heyman; Brent A Blumenstein; Ira Kalfus; Michael M Frank
Journal:  N Engl J Med       Date:  2010-08-05       Impact factor: 91.245

8.  Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks.

Authors:  Richard L Wasserman; Robyn J Levy; Againdra K Bewtra; David Hurewitz; Timothy J Craig; Peter C Kiessling; Heinz-Otto Keinecke; Jonathan A Bernstein
Journal:  Ann Allergy Asthma Immunol       Date:  2010-11-20       Impact factor: 6.347

9.  Acquired angioedema.

Authors:  Marco Cicardi; Andrea Zanichelli
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

10.  Increasing hospitalizations due to angioedema in the United States.

Authors:  Robert Y Lin; Shaili N Shah
Journal:  Ann Allergy Asthma Immunol       Date:  2008-08       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.